Home»Exposition»Beactica Signs Three-Year Extension Agreement With Sanofi

Beactica Signs Three-Year Extension Agreement With Sanofi

0
Shares
Pinterest Google+

UPPSALA, Sweden, May 27, 2018 /PRNewswire/ — Beactica, the Swedish drug discovery company with world-leading expertise in molecular interactions, today announced that it has signed a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms…

Previous post

Cashaa Will Enable Payments for the Billion Dollar Freelancer Marketplace Industry

Next post

Stihl TIMBERSPORTS® Champions Trophy 2018 in Marseille